Roux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome

scientific article published on 16 May 2015

Roux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11695-015-1729-0
P698PubMed publication ID25975201
P5875ResearchGate publication ID276358619

P2093author name stringSahruh Turkmen
Alebtekin Ahangari
Torbjörn Bäckstrom
P2860cites workMetformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndromeQ46979548
Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.Q47729893
Effects of Roux-en-Y gastric bypass surgery on eating behaviour and allopregnanolone levels in obese women with polycystic ovary syndromeQ47770586
Long-Term Testosterone Administration Increases Visceral Fat in Female to Male Transsexuals1Q50947802
Relationships between obesity, lipids and fasting glucose in the menopause.Q51342480
Carbohydrate and lipid metabolic studies before and after one year of treatment with ethynodiol diacetate in "normal" womenQ51670406
Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma.Q51732016
Metabolic effects of progesterone.Q54329204
Prospective studies of carbohydrate metabolism in "normal" women using norgestrel for eighteen monthsQ67276306
Divergent effects of d-norgestrel on the metabolism of rat very low density and low density apolipoprotein BQ69621905
Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapyQ70449324
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypassQ80151319
Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysisQ82955825
Effects of gastric bypass surgery on female reproductive functionQ23920160
Surgery for obesityQ24241212
Tolerance to allopregnanolone with focus on the GABA-A receptorQ30471700
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Q34285382
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes FederationQ34567335
Epidemiology, diagnosis, and management of polycystic ovary syndromeQ34658641
Defining the role of bariatric surgery in polycystic ovarian syndrome patientsQ35906974
Abdominal adiposity and the polycystic ovary syndrome.Q36908020
Role of obesity and adiposity in polycystic ovary syndromeQ36984918
The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention programQ37126271
Polycystic ovary syndrome: treatment strategies and managementQ37327330
Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal womenQ37499223
Sex hormones, metabolic syndrome and kidneyQ37861243
Steroid hormones interrelationships in the metabolic syndrome: an introduction to the ponderostat hypothesisQ38036222
Allopregnanolone: state of the art.Q38152199
Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.Q38211907
Metabolic syndrome and risk of cardiovascular disease: a meta-analysisQ39015722
Clinical significance of the androgenicity of progestins in hormonal therapy in women.Q41989622
Effect of progesterone on lipid metabolism in the intact rat.Q42467228
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS.Q42972731
Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clampQ43059504
Allopregnanolone induces a diurnally dependent hyperphagic effect and alters feeding latency and duration in male Wistar ratsQ43478161
Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndromeQ43668598
Infertility following wedge resection of the ovariesQ44355342
Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.Q44422744
Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistanceQ45729814
Pharmacokinetic and behavioral effects of allopregnanolone in healthy womenQ46715578
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistanceQ46774556
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.Q46871128
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levelsQ46916550
P433issue1
P921main subjectpolycystic ovaryQ5547896
polycystic ovary syndromeQ500816
metabolic syndromeQ657193
P304page(s)111-118
P577publication date2015-05-16
P1433published inObesity SurgeryQ15762541
P1476titleRoux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome
P478volume26

Reverse relations

cites work (P2860)
Q41116375Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy
Q41640666The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Q36226209The association between severity of King's Obesity Staging Criteria scores and treatment choice in patients with morbid obesity: a retrospective cohort study

Search more.